Joint Action Rare Cancer


  • Client:  EU Joint Action on Rare Cancer (JARC)
  • Info:+30 |

View Project

The Joint Action on Rare Cancers is a multistakeholders collaboration between 18 Member States and European Commission, coordinated by the Fondazione IRCCS Istituto Nazionale dei Tumori of Milan.

There are 34 partners involved in the JARC including Ministries of  Health/Cancer Control Programmes representatives (Cyprus, Czech Republic, France, Ireland, Italy, Malta, Poland and Spain), universities, public health health institutions, population-based cancer registries, oncological onstitutes, patients associations (ECPC, EURORDIS, CCI-Europe) and other societies/organisations (including the Organisation of European Cancer Institutes - OECI and European Society for Pediatric Oncology - SIOPE).